078140 — Daebongls Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Daebongls Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6,239	7,395	10,042	11,794	6,182
Depreciation
Amortisation
Non-Cash Items	1,967	1,473	786	-3,048	-2,963
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4,497	4,240	-3,667	-3,084	-728
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6,046	15,702	10,099	8,776	5,889
Capital Expenditures	-7,280	-8,676	-6,421	-5,674	-9,586
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3,294	-46,814	-9,695	-16,104	7,353
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-10,574	-55,490	-16,116	-21,779	-2,233
Financing Cash Flow Items	—	15,675	0	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	6,981	38,164	2,147	14,044	3,343
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,453	-1,718	-3,869	1,041	7,002